Tyisha Hathorn, Ph.D.
Affiliations: | 2010 | Albany Medical College of Union University |
Area:
Neurobiology BiologyGoogle:
"Tyisha Hathorn"Mean distance: 42746.4
Parents
Sign in to add mentor| Anne Messer | grad student | 2010 | Albany Medical College of Union University | |
| (Evaluation of multiple therapeutic approaches for the treatment of Huntington's disease: Intrabodies and nicotinamide.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Khare S, Nick JA, Zhang Y, et al. (2017) A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. Plos One. 12: e0173565 |
| Armbrust KR, Wang X, Hathorn TJ, et al. (2014) Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9891-904 |
| Hathorn T, Snyder-Keller A, Messer A. (2011) Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease. Neurobiology of Disease. 41: 43-50 |
| Snyder-Keller A, McLear JA, Hathorn T, et al. (2010) Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6/1 mice. Journal of Neuropathology and Experimental Neurology. 69: 1078-85 |